Redcare Pharmacy report says EU drug shortages often stem from distribution gaps, not supply
Bitget2026/10/05 08:02Redcare Pharmacy published an expert report arguing Europe’s critical medicine shortages are often a distribution issue, not a supply issue. Analysis tracked shortages for 49 critical medicines across six countries, highlighting mismatches where some markets run short despite EU availability elsewhere. The report flags EU-wide cross-border e-prescriptions via MyHealth@EU as a potential route to shift dispensing across borders once fully available from Q1 2029. It positions authorized online pharmacies connected to MyHealth@EU as a channel to route available stock to patients, supporting EHDS objectives. Recommendations center on faster EHDS rollout, online pharmacy integration, harmonized e-prescription standards, and clearer reimbursement and governance frameworks. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redcare Pharmacy NV published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.
- Redcare Pharmacy published an expert report arguing Europe’s critical medicine shortages are often a distribution issue, not a supply issue.
- Analysis tracked shortages for 49 critical medicines across six countries, highlighting mismatches where some markets run short despite EU availability elsewhere.
- The report flags EU-wide cross-border e-prescriptions via MyHealth@EU as a potential route to shift dispensing across borders once fully available from Q1 2029.
- It positions authorized online pharmacies connected to MyHealth@EU as a channel to route available stock to patients, supporting EHDS objectives.
- Recommendations center on faster EHDS rollout, online pharmacy integration, harmonized e-prescription standards, and clearer reimbursement and governance frameworks.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
This AI Stock Exploded 600% in a Year, Beating Nvidia and Micron
House Finance panel chair says regulator actions on crypto ‘fall short’ of CLARITY bill
Vietnam: Strong GDP but rising inflation risks – Commerzbank
Incordex appoints Chen Wang to board of directors
Incordex appointed Chen Wang to its board effective Sept. 29, 2026. Wang founded his own brand. He has served as founder and board chairman of Yunnan Jinshengchang Technology and Trade since Oct. 2024. He previously led global pharmaceutical education operations at Meixin E-commerce. He later ran education operations at Zhuyuan Grop. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incordex Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-006080), on October 07, 2026, and is solely responsible for the information contained therein.
Crypto prices
More
